When to take omega-3

Short answer

Taking omega-3 in the morning or evening has not been shown to change the effect. The only concrete timing information measured concerns absorption: in one study, absorption of the high-dose ethyl ester form depended strongly on meal fat; this cannot be directly generalized to the typical low-dose capsules on the market. Blood level depends on intake over months, not on a single dose. For people taking anticoagulants, the described precaution is monitoring, not a time interval. ^{[2] [1]}

Is omega-3 taken with food?

There is a biologically plausible rationale: according to NIH, omega-3s are absorbed in the intestine like other dietary fats (about 95%) and pass into intestinal cells with bile salt micelles. ^[1] This makes it expected that meal fat affects absorption; the question is how important this is for individual products.

The study that measured this directly is a comparison of two products. In 54 overweight adults, with a randomized-sequence, open-label, single-dose, four-period crossover design, a free fatty acid omega-3 product and a prescription ethyl ester product were compared at single 4 g doses in both low-fat and high-fat consumption periods. In the low-fat period, the 24-hour EPA+DHA absorption area (AUC) was 2,650.2 nmol·h/mL for the free fatty acid product and 662.0 for the ethyl ester (a 4.0-fold difference); in the high-fat period the difference was about 1.3-fold. In the low-fat period, 30 of 51 people (58.8%) taking free fatty acid reached at least half of their own high-fat period AUC; among those taking ethyl ester, this was 3 of 50 people (6.0%). ^[2]

Limits of this study: (1) It is a single-dose pharmacokinetic study; it does not measure disease outcomes. (2) The doses are 4 g; they may not equal the 1 g capsules on the market. (3) The free fatty acid product compared is the product of the company that conducted the study; the author affiliation listed in PubMed is the pharmaceutical company that developed this product. (4) The abstract does not give the low-fat and high-fat period values for ethyl ester separately; the main result is the difference and ratios between the two products. In conclusion, there is a sign that meal fat matters for absorption in ethyl ester products; an effect of the same size has not been shown for other forms and low-dose capsules. ^[2]

The difference in form also interferes with timing. In the Dyerberg study of 72 volunteers, with about 3.3 g/day EPA+DHA at the end of 2 weeks of intake, bioavailability relative to natural fish oil was 124% for re-esterified triglyceride, 91% for free fatty acid and 73% for ethyl ester. ^[3] In the older single-dose study by Lawson and Hughes in eight men, ethyl esters were reported to be absorbed at only about one fifth of free fatty acids. ^[4] That ethyl ester is the least absorbed form is common to both studies; meal conditions are not stated in these summaries. Details of the forms are on the fish oil page.

Detailed guideFish oil: forms, krill, algal oil and label reading→

Morning or evening?

The time of day has not been shown to change the effect of omega-3; claims that “morning is better” or “evening is better” are not based on data. Blood level and long-term effect depend more on total intake than on the time of a single dose: according to NIH, EPA+DHA in the erythrocyte membrane reflects intake over roughly the previous 120 days, whereas plasma values change markedly with the most recent meal. ^[1]

Once a day or split?

In REDUCE-IT, the total daily dose of 4 g was given as 2 g twice daily. ^[6] This is the design of the trial; it is not a comparison showing that a split dose is better or worse than a single dose. VITAL and ASCEND, by contrast, used the same 1 g/day formulation. ^[1] Which schedule suits whom, and the product type and dose, are determined with a physician or pharmacist; this guide does not recommend doses or schedules.

Does fish oil cause burping or upset the stomach?

According to NIH, the commonly reported adverse effects of omega-3 supplements are generally mild: unpleasant taste, bad breath, heartburn, nausea, digestive discomfort, diarrhea, headache and odorous sweat. ^[1] That taking it with food or in split doses reduces these complaints is not among the information reported by NIH. When there is persistent discomfort, the product, dose and form are reviewed with a physician or pharmacist.

Oxidation and quality are covered separately on the fish oil page; EFSA’s safety assessment is also conditional on oxidative stability being ensured. ^[5]

Timing with anticoagulants and other medications

NIH reports that fish oil at high doses may have an antiplatelet effect (appearing weaker than aspirin) and may raise INR with warfarin, but that most research shows 3–6 g/day of fish oil does not significantly change anticoagulant status in people taking warfarin. The prescribing information of FDA-approved omega-3 drugs calls for INR to be monitored at regular intervals with concomitant anticoagulant use. ^[1] The precaution described for this interaction is therefore monitoring by a physician, not a time interval; the interaction section of NIH does not include a specific time gap between omega-3 and anticoagulants.

EFSA concluded that long-term EPA+DHA supplementation up to about 5 g/day does not increase the risk of spontaneous bleeding or bleeding complications; in REDUCE-IT, serious bleeding was 2.7% in the group taking 4 g/day and 2.1% in the placebo group (P=0.06). ^{[5] [6]}

Detailed guideWhat is omega-3? EPA, DHA, ALA, evidence and safety→ Detailed guideOmega-3 benefits: which claims are supported?→

This guide does not recommend personal doses or timing; the product’s prescribing information and the physician or pharmacist take precedence.